GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (FRA:6GJ) » Definitions » Other Gross PPE

Glaukos (FRA:6GJ) Other Gross PPE : €176.9 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Glaukos Other Gross PPE?

Glaukos's Other Gross PPE for the quarter that ended in Dec. 2024 was €176.9 Mil.

Glaukos's quarterly Other Gross PPE declined from Jun. 2024 (€157.6 Mil) to Sep. 2024 (€151.6 Mil) but then increased from Sep. 2024 (€151.6 Mil) to Dec. 2024 (€176.9 Mil).

Glaukos's annual Other Gross PPE increased from Dec. 2022 (€148.9 Mil) to Dec. 2023 (€157.3 Mil) and increased from Dec. 2023 (€157.3 Mil) to Dec. 2024 (€176.9 Mil).


Glaukos Other Gross PPE Historical Data

The historical data trend for Glaukos's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Other Gross PPE Chart

Glaukos Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.48 90.80 148.92 157.27 176.92

Glaukos Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 158.35 157.59 151.61 176.92 157.43

Glaukos Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Glaukos Business Description

Traded in Other Exchanges
Address
One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Headlines

No Headlines